CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-18 | Gardiner Nathaniel S. Sr. VP & General Counsel | Option exercise | +6,667 | $30.00 | $200K | 79,980 |
| 2023-04-18 | Gardiner Nathaniel S. Sr. VP & General Counsel | Option exercise · Stock Option (Right to Buy) | −6,667 | 7,000 | ||
| 2023-03-16 | Vance Terry Director | Option exercise | +5,800 | $14.00 | $81K | 21,095 |
| 2023-03-16 | Vance Terry Director | Option exercise · Stock Option (right to buy) | −5,800 | 0 | ||
| 2023-03-15 | MELLETT PAUL J Treasurer and CFO | Option exercise | +10,440 | $14.00 | $146K | 107,996 |
| 2023-03-15 | MELLETT PAUL J Treasurer and CFO | Sale | −100 | $43.96 | $4K | 107,896 |
| 2023-03-15 | MELLETT PAUL J Treasurer and CFO | Sale | −10,340 | $44.43 | $459K | 97,556 |
| 2023-03-15 | MELLETT PAUL J Treasurer and CFO | Option exercise · Stock Option (Right to Buy) | −10,440 | 0 | ||
| 2023-03-15 | Or Yat Sun Sr. VP & CSO | Option exercise | +13,925 | $14.00 | $195K | 388,627 |
| 2023-03-15 | Or Yat Sun Sr. VP & CSO | Sale | −269 | $43.92 | $12K | 388,358 |
| 2023-03-15 | Or Yat Sun Sr. VP & CSO | Sale | −13,656 | $44.46 | $607K | 374,702 |
| 2023-03-15 | Or Yat Sun Sr. VP & CSO | Option exercise · Stock Option (Right to Buy) | −13,925 | 0 | ||
| 2023-03-13 | Luly Jay R. President and CEO | Option exercise | +27,912 | $14.00 | $391K | 847,722 |
| 2023-03-13 | Luly Jay R. President and CEO | Sale | −10,697 | $44.81 | $479K | 837,025 |
| 2023-03-13 | Luly Jay R. President and CEO | Sale | −15,649 | $45.31 | $709K | 821,376 |
| 2023-03-13 | Luly Jay R. President and CEO | Sale | −1,566 | $46.13 | $72K | 819,810 |
| 2023-03-13 | Luly Jay R. President and CEO | Option exercise · Stock Option (Right to Buy) | −27,912 | 0 | ||
| 2023-03-02 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +10,800 | 10,800 | ||
| 2023-03-02 | Russell Lesley Director | Grant or award · Stock Option (right to buy) | +10,800 | 10,800 | ||
| 2023-03-02 | Peterson Kristine Director | Grant or award · Stock Option (right to buy) | +10,800 | 10,800 |
Page 8 of 19 · 377 trades